|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▼
|
Status ▲
|
|
AVALGLUCOSIDASE ALFA |
A16AB22 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005501 |
24-06-2022 |
VALID
|
|
OLIPUDASE ALFA |
A16AB25 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
CAPMATINIB |
L01EX17 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004845 |
20-06-2022 |
VALID
|
|
LINZAGOLIX |
H01CC04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005442 |
14-06-2022 |
VALID
|
|
CILTACABTAGENE AUTOLEUCEL |
L01XL05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005095 |
25-05-2022 |
VALID
|
|
RELUGOLIX |
L02BX04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005353 |
29-04-2022 |
VALID
|
|
DIFELIKEFALIN |
V03AX04 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005612 |
25-04-2022 |
VALID
|
|
INEBILIZUMAB |
L04AG10 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005818 |
25-04-2022 |
VALID
|
|
RIMEGEPANT |
N02CD06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005725 |
25-04-2022 |
VALID
|
|
ENFORTUMAB VEDOTIN |
L01FX13 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005392 |
13-04-2022 |
VALID
|
|
TEBENTAFUSP |
L01XX75 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004929 |
01-04-2022 |
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
|
SOMATROGON |
H01AC08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005633 |
14-02-2022 |
VALID
|
|
VOXELOTOR |
B06AX03 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004869 |
14-02-2022 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
EPTINEZUMAB |
N02CD05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
|
AVACOPAN |
L04AJ05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005523 |
11-01-2022 |
VALID
|
|
LONAPEGSOMATROPIN |
H01AC09 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005367 |
11-01-2022 |
VALID
|
|
SOTROVIMAB |
J06BD05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005676 |
17-12-2021 |
VALID
|
|
PEGCETACOPLAN |
L04AJ03 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005553 |
13-12-2021 |
VALID
|
|
SACITUZUMAB GOVITECAN |
L01FX17 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005182 |
22-11-2021 |
VALID
|
|
PRALSETINIB |
L01EX23 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005413 |
18-11-2021 |
VALID
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
REGDANVIMAB |
J06BD06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005854 |
12-11-2021 |
VALID
|
|
TAFASITAMAB |
L01FX12 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005436 |
26-08-2021 |
VALID
|
|
BIMEKIZUMAB |
L04AC21 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005316 |
20-08-2021 |
VALID
|
|
ROXADUSTAT |
B03XA05 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/004871 |
18-08-2021 |
VALID
|
|
ELIVALDOGENE AUTOTEMCEL |
A16AX21 |
PT
|
POM
|
|
EMEA/H/C/003690 |
16-07-2021 |
VALID
|
|
ODEVIXIBAT |
A05AX05 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/004691 |
16-07-2021 |
VALID
|
|
SETMELANOTIDE |
A08AA12 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005089 |
16-07-2021 |
VALID
|
|
TIRBANIBULIN |
D06BX03 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005183 |
16-07-2021 |
VALID
|
|
VERICIGUAT |
C01DX22 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005319 |
16-07-2021 |
VALID
|
|
SATRALIZUMAB |
L04AC19 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/004788 |
24-06-2021 |
VALID
|
|
EVINACUMAB |
C10AX17 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005449 |
17-06-2021 |
VALID
|
|
TRALOKINUMAB |
D11AH07 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005255 |
17-06-2021 |
VALID
|
|
DROSPIRENONE AND ESTETROL |
G03AA18 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005336 |
19-05-2021 |
VALID
|
|
DUVELISIB |
L01EM04 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005381 |
19-05-2021 |
VALID
|
|
PONESIMOD |
L04AE04 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005163 |
19-05-2021 |
VALID
|
|
BEROTRALSTAT |
B06AC06 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005138 |
30-04-2021 |
VALID
|
|
DOSTARLIMAB |
L01FF07 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005204 |
21-04-2021 |
VALID
|
|
SOMAPACITAN |
H01AC07 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005030 |
31-03-2021 |
VALID
|
|
OFATUMUMAB |
L04AG12 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005410 |
26-03-2021 |
VALID
|
|
REMIMAZOLAM |
N05CD14 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005246 |
26-03-2021 |
VALID
|
|
SELPERCATINIB |
L01EX22 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005375 |
11-02-2021 |
VALID
|
|
TUCATINIB |
L01EH03 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005263 |
11-02-2021 |
VALID
|
|
FEDRATINIB |
L01XE57 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005026 |
08-02-2021 |
VALID
|
|
FOSTEMSAVIR |
J05AX29 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005011 |
04-02-2021 |
VALID
|
|
TRASTUZUMAB DERUXTECAN |
L01FD04 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005124 |
18-01-2021 |
VALID
|
|
TAGRAXOFUSP |
L01XX67 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005031 |
07-01-2021 |
VALID
|
|
COVID-19 VACCINES |
J07BX03 |
PT
|
POM
|
26-01-2021 |
EMEA/H/C/005735 |
21-12-2020 |
VALID
|